The first FDA-cleared prescription wearable device for low bone density launches in the U.S.

When most folks talk about aging, they picture wrinkles, silver hair, maybe a few vitamins — rarely does anyone bring up bones. But for over 60 million Americans, brittle bones are more than a nuisance; they're a looming threat to independence and mobility. That's where Osteoboost steps in, shaking up the status quo with a belt, some gentle vibration, and a whole lot of science. It's the first-ever FDA-cleared, drug-free prescription device for low bone density.

"The longevity conversation is everywhere," says CEO Laura Yecies. "But people rarely mention bone health — even though it's fundamental to aging with confidence."

How does it work?

Osteoboost looks like a simple wearable, but don't let appearances fool you. It's a medical-grade device with a sophisticated edge, delivering:

• Targeted vibration therapy: focused on the spine and hips, the areas most prone to fractures
• 30 minutes a day: use it while walking, cooking, or folding laundry
• Clinically proven results: based on a double-blinded, placebo-controlled trial

In that gold-standard study, postmenopausal women using Osteoboost at least three times per week saw:

• 85% less loss in spine bone density
• 83% less loss in spine bone strength
• 55% less loss in hip bone density

And get this — over 80% of participants actually stuck with it. No serious side effects, no hard-to-swallow pills, no hassle.

Why does it matter?

We're not just talking aches and creaks. Fragile bones break lives wide open. More women will suffer osteoporotic fractures than heart attacks, strokes, and breast cancer combined. And those breaks? They cost the U.S. healthcare system $46 billion each year.

Yet, most treatments don't start until after a fracture. That's a bit like waiting for your roof to collapse before calling the contractor. Osteoboost is flipping the script.

"This is the first real innovation we've seen in bone health in a long time," says Dr. Yevgeniya Kushchaeva, Medical Director of the Adult Osteoporosis Program at the University of South Florida. "My patients are already asking about it. I'm prescribing it — and I'm hopeful."

The context

Osteopenia — bone loss that precedes osteoporosis — is wildly under-treated. Over half of U.S. postmenopausal women fall into this category, yet there's been practically nothing in their toolbox. Calcium and vitamin D? Helpful, but not enough. Meds? Usually reserved for those already fractured.

Osteoboost plugs that gaping hole. It's:

• Cleared as a Class II medical device
• Recognized as a Breakthrough Device by the FDA
• Supported by new backing from AARP, Harvard Business School Angels, and Esplanade Ventures

With over 1,000 physicians already prescribing it — including from 30+ top-tier academic medical centers — it's safe to say the demand is real.

And to make it even easier, Osteoboost teamed up with Beluga Health to offer online prescription consults. No waiting rooms, no foot-dragging — just proactive, at-home care. That's a game-changer for women looking to stand tall, stay strong, and live well on their own terms.

As Yecies puts it, "Osteoboost empowers people to lead longer, stronger, and more active lives." Now that's a future worth standing for.